eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | Classifieds | Contact | More... | Topics | Search | Login | Buy full access   

Letters

Words, words, words

Warwick H Ruse
MJA 2007; 187 (4): 255-256

To the Editor: Could I use a tiny fragment of a recent article as springboard to a plea for a change in terminology?

Wilcken et al refer to two observations on the use of tamoxifen changing clinical practice, “and thousands of lives were potentially saved”.1 Are we fooling ourselves? Surely it is more accurate to say, in the situation of breast cancer in lives already well advanced, that thousands of deaths were postponed? “Humankind cannot bear very much reality.”2

Could we leave “lives saved” to the populist sensationalist media, and only use it in medicine for interventions in trauma, and possibly infection, in young people whose life expectancy is otherwise so good that their life has been truly “saved”?

“. . . speech impelled us to purify the dialogue of the tribe and urge the mind to aftersight and foresight . . .”3

Warwick H Ruse, Physician

Perth, WA.

harusepxATbigpond.com

  1. Wilcken NR, Gebski VJ, Pike R, Keech AC. Putting the results of a clinical trial into perspective. Med J Aust 2007; 186: 368-370. <eMJA full text> <PubMed>
  2. Eliot TS. Burnt Norton (Four quartets. No. 1). In: Collected poems 1909–1962. London: Faber and Faber, 1963: 190.
  3. Eliot TS. Little Gidding (Four quartets. No. 4). In: Collected poems 1909–1962. London: Faber and Faber, 1963: 218.

(Received 11 Apr 2007, accepted 6 Jun 2007)

Nicholas R Wilcken, Val J Gebski, Anthony C Keech and Rhana Pike

In reply: We agree that attention to terminology is important, and that claims about potential medical advances are often exaggerated. On the other hand, on the rare occasions when things go really well, we should not hide our light under a bushel.

In the overview cited in our article, the risk of death 15 years after diagnosis was about 35% for the controls and about 25% for those who were given tamoxifen for 5 years1 — a reduction in the death rate of about a third. Another example is the finding from the earliest chemotherapy trials that significantly more women in the treatment arms were alive nearly 30 years later,2 showing that postoperative systemic therapy can have very long-lasting effects on the chances of being alive or dead. Over the years, this adds up to a lot of women not dead from breast cancer.

However, whether these are really “lives saved” may be more a philosophical than a medical question. It is true that, despite decades of research and billions of dollars spent, the mortality rate remains at 1.0 per person, and death still consumes much of our thoughts.3 Rather than “lives were potentially saved”, perhaps a compromise could have been the less poetic “breast cancer deaths were avoided”.

Nicholas R Wilcken, Coordinating EditorVal J Gebski, Principal Research FellowAnthony C Keech, Deputy DirectorRhana Pike, Publications Officer

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.

rhanaATctc.usyd.edu.au

  1. Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-1717. <PubMed>
  2. Bonadonna G, Moliterni A, Zambetti M, et al. 30 years’ follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ 2005; 330: 217. <PubMed>
  3. Eliot TS. The journey of the Magi. In: Collected poems 1909–1962. London: Faber and Faber, 1963: 109.

(Received 22 May 2007, accepted 6 Jun 2007)

Home | Issues | eMJA shop | Terms of use | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  

©The Medical Journal of Australia 2007 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377